| 摘要 |
FIELD: chemical-pharmaceutical industry. SUBSTANCE: invention relates to application of the early known methylmethioninesulfonium diaquatrichlorocuprate of the formula (I). Compound shows positive effect on liver and decreases activity of aspartic acid aminotransferase and alkaline phosphatase and total bilirubin content in animal damaged liver (by 12.12; 32.24 and 52.62%, respectively) and increases total protein level in blood serum by 8.15%. Agent improves result of colloidal-precipitating reaction. Agent can be used as medicinal drug for recovery of morphofunctional liver state, its protein-synthetic and detoxicating functions. Agent shows low toxicity, its LD= 850 mg/kg at intraperitoneal administration to white mice. EFFECT: low toxicity, broad spectrum of therapeutic action, hepatotropic action. |
